AbbVie Inc. — Director's Dealing 2025

Feb 28, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AbbVie Inc. (ABBV)
CIK: 0001551152
Period of Report: 2025-02-26

Reporting Person: Buckbee Kevin K (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-02-26	Common Stock, $0.01 par value	S	2684	$203.40	Disposed	12646	Direct
2025-02-26	Common Stock, $0.01 par value	M	9738	$93.50	Acquired	22384	Direct
2025-02-26	Common Stock, $0.01 par value	M	6522	$105.92	Acquired	28906	Direct
2025-02-26	Common Stock, $0.01 par value	S	16260	$203.41	Disposed	11496	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-02-26	Option (Right to buy)	$93.50	M	9738	Disposed	2030-02-19	Common Stock (9738)	Direct
2025-02-26	Option (Right to buy)	$105.92	M	6522	Disposed	2031-02-17	Common Stock (6522)	Direct

Footnotes

F1: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $203.39 to $203.48, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2: The reporting person transferred 1,150 shares of common stock to his former spouse pursuant to a domestic relations order since his last ownership report and has ceased to be the beneficial owner of such shares.

F3: Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.